Paradigm Spine, LLC Announces Publication Of ISASS Guidelines Recommending Coverage Of Interlaminar Stabilization®
NEW YORK, Dec. 6, 2016 /PRNewswire/ — Paradigm Spine, LLC, a leader in providing solutions for the treatment of lumbar spinal stenosis (LSS)…Read More »
Paradigm BioDevices, Inc. Completes 25,000th Procedure with the QuickDraw MIS Bone Harvester™ and Reports Positive Independent Clinical Findings.
October 19, 2016 ROCKLAND, Mass.–(BUSINESS WIRE)–Paradigm BioDevices, Inc. announced today that it completed its 25,000th case with its proprietary MIS…Read More »
PDL BioPharma Announces the Successful Conclusion of its Debt Financing Agreement with Paradigm Spine
INCLINE VILLAGE, Nev., Aug. 29, 2016 /PRNewswire/ — PDL BioPharma, Inc. (NASDAQ: PDLI) (PDL or the Company) today announced that PDL has received approximately $57.4…Read More »